ImCheck Therapeutics
Develops immunotherapeutic antibodies targeting butyrophilins and gamma-delta T cells for cancer, infectious disease, and autoimmune disease treatment.
Backed by Agent Capital, LLC, Decheng Capital LLC, Kurma Partners
Traction is an independent job board.
This listing is read from the company’s own careers page and links straight back to it. We never receive your application.